Tirzepatide

The dual-agonist that redefined metabolic regulation.

Vial Size

Includes syringes & alcohol pads

HPLC-verified ≥99% purity · Certificate of Analysis

Order Now Ask a Question

Dose Range

2.5–15 mg

Route

Subcutaneous

Frequency

Once weekly

Stability

30 days refrigerated

The Science

Two receptors working in concert.

Tirzepatide activates both GLP-1 and GIP receptors — a dual mechanism that expanded what metabolic peptides can do. GLP-1 regulates satiety and insulin release. GIP contributes a complementary signal that refines glycemic control and influences fat metabolism.

The molecule that the medical world now knows by its brand names was not an accident. It is one of the most studied metabolic peptides of the past decade, and its effects on appetite, body composition, and glucose handling are well-characterized.

Researched Benefits

Satiety Signaling

GLP-1 engagement reduces appetite and supports adherence.

Glycemic Control

Glucose-dependent insulin release without the hypoglycemia risk of older agents.

Fat Metabolism

Researched for effects on visceral and subcutaneous adiposity.

Slow GI Transit

Delayed gastric emptying that reinforces satiety between meals.

The Protocol

Reconstitution & Administration

Reconstitute with bacteriostatic water and store refrigerated. Standard titration begins at 2.5mg for four weeks before climbing.

Suggested Dose

2.5–15 mg

Frequency

Once weekly

This information is for research context. Any decisions about personal use — including dosing, timing, and cycle length — should involve a licensed medical provider familiar with your individual health.

What to Expect

The Timeline

Tirzepatide is dosed once weekly. Standard titration starts at 2.5mg for four weeks, climbing to 5mg, 7.5mg, 10mg, 12.5mg, and 15mg as tolerated — each step held for at least four weeks. Appetite effects are typically felt within the first month.

Stack It With

Often paired with: